Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Reem, Ameen"'
Publikováno v:
Cancer Medicine
The epidemiology, genetics, and thrombosis risk of MPNs among Arabs are largely unknown. This may be attributed to scarce epidemiological data, particularly from our region. Our study included 381 Kuwaiti nationals with Ph‐negative MPNs and a confi
Publikováno v:
HLA. 100:549-550
One nucleotide substitution in codon 85 of HLA-DPA1*01:03:01:04 results in a novel allele HLA-DPA1*01:03:34.
Publikováno v:
HLA. 100:546-547
One nucleotide substitution in codon 179 of HLA-DRB4*01:03:01:01 results in a novel allele HLA-DRB4*01:152.
Autor:
Regina Spinnler, Nayera Hamdy, Ingrid Fae, Tamara Vayntrub, Katerina Tarassi, Marcelo Fernandez-Vina, Michael Halagan, Alexandra Tsirogianni, Bernd M. Spriewald, Medhat Askar, Maria Beatriz Rodriguez, Leah Zhrebker, Gideon Hönger, Gottfried Fischer, Karin Padros, Abeer Madbouly, Reem Ameen, Arthur Dunk, Shawna Kennedy, Ronald K. Charlton, Ghada I. Mossallam, Christian Bach, Salem Al Shemmari, Amanda Willis, Kazutoyo Osoegawa
Publikováno v:
Human Immunology. 80:897-905
Since their inception, the International HLA & Immunogenetics Workshops (IHIW) served as a collaborative platform for exchange of specimens, reference materials, experiences and best practices. In this report we present a subset of the results of hum
Autor:
Salem H. Alshemmari, Tamara Vayntrub, Marcelo A. Fernández-Viňa, Ileana Constantinescu, Milena Ivanova, Bushra Al Hadra, Elissaveta Naumova, Tsvetelin Lukanov, Larisa Denisa Ursu, Michela Mazzocco, Reem Ameen, Velizar Shivarov, Ana Moise, Lisa E. Creary, Nicoletta Sacchi
Publikováno v:
Hum Immunol
The ‘Immunogenetics of Aging’ project is a component introduced in the 14th International HLA and Immunogenetics Workshop (IHIW) and developed further within subsequent workshops. The aim was to determine the relevance of immunogenetic markers, f
Autor:
Nashmi Alshammari, Azeez Alzafiri, Abdulrahman Alshammari, Alia Embaireeg, Najat A. Rouheldeen, Mariam Ayed, Sondas Ibrahim Alsharidah, Fatma Alhuraish, Salem Alqahtani, Abdullah Alsaeedi, Farah R. Alshammari, Enas F. Gouda, Reem Ameen, Mohammad A. Aljasmi, Maitham Adel, Mohammad Almehanna, Medhat Askar, Husain Awad, Humoud A. Alenezi, Mohammed E. Dawoud, Hussan Arian, Wasel Al-Adsani, Mariam Almelahi
Publikováno v:
International Journal of Infectious Diseases
International Journal of Infectious Diseases, Vol 103, Iss, Pp 439-446 (2021)
International Journal of Infectious Diseases, Vol 103, Iss, Pp 439-446 (2021)
Highlights • Convalescent plasma is adjunct treatment in COVID-19 moderate and severe disease. • Clinical improvement is noticed in COVID-19 disease after convalescent plasma. • Mortality is significantly reduced after COVID-19 convalescent pla
Publikováno v:
Clinical lymphoma, myelomaleukemia. 21(7)
Background Philadelphia-negative myeloproliferative neoplasms (MPNs) are a group of hematopoietic stem cell disorders that include polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). This study examines the driver
Autor:
Raewyn Fisher, John Mavrommatis, Jane Kempenich, Heather Dunckley, Jan A. Hofmann, Ahmed Alaskar, Tigran Torosian, Kim Wadsworth, Pavel Jindra, Ankit Mathur, Irene Andersen, Mohsen Alzahrani, Anastasios Manolis, Nicoletta Sacchi, Alexander H. Schmidt, Pawinee Kupatawintu, Carolyn Katovich Hurley, Jürgen Sauter, Latha Jagannathan, Betina Samuelsen Sørensen, Grazia Nicoloso, Nira Shriki, Pablo E. Galarza, Nezih Cereb, Malgorzata Dudkiewicz, Reem Ameen, Maria Belen Rodriguez Cardozo, Dunia Jawdat, Sigal Manor, Mats Bengtsson, Lucie Houdová, Ali H. Hajeer, Ashminder Kaur, Louise Cho, Jason Dehn, Rafi Freudenberger, Daniel Schefzyk, Tiina Linjama
Publikováno v:
Hurley, C K, Kempenich, J, Wadsworth, K, Sauter, J, Hofmann, J A, Schefzyk, D, Schmidt, A H, Galarza, P, Cardozo, M B R, Dudkiewicz, M, Houdova, L, Jindra, P, Sorensen, B S, Jagannathan, L, Mathur, A, Linjama, T, Torosian, T, Freudenberger, R, Manolis, A, Mavrommatis, J, Cereb, N, Manor, S, Shriki, N, Sacchi, N, Ameen, R, Fisher, R, Dunckley, H, Andersen, I, Alaskar, A, Alzahrani, M, Hajeer, A, Jawdat, D, Nicoloso, G, Kupatawintu, P, Cho, L, Kaur, A, Bengtsson, M & Dehn, J 2020, ' Common, intermediate and well-documented HLA alleles in world populations : CIWD version 3.0.0 ', HLA, vol. 95, no. 6, pp. 516-531 . https://doi.org/10.1111/tan.13811
Hla
Hla
A catalog of common, intermediate and well-documented (CIWD) HLA-A, -B, -C, -DRB1, -DRB3, -DRB4, -DRB5, -DQB1 and -DPB1 alleles has been compiled from over 8 million individuals using data from 20 unrelated hematopoietic stem cell volunteer donor reg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25fc2d2e6d9698eee8da3c13241896e5
https://pure.au.dk/ws/files/220333787/tan.13811.pdf
https://pure.au.dk/ws/files/220333787/tan.13811.pdf
Publikováno v:
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. 59(4)
Ethnic differences in blood group frequencies might result in clinically important mismatches for transfusions. Arab people represent a large population for which no comprehensive database of red cell genotypes is available and Kuwaitis are no except
Autor:
Mariam Almelahi, Mohammed E. Dawoud, Abdulrahman Alshammari, Salem Alqahtani, Mariam Ayed, Mohammad Almehanna, Najat A. Rouheldeen, Humoud A. Alenezi, Medhat Askar, Farah R. Alshammari, Reem Ameen, Mohammad A. Aljasmi, Abdullah Alsaeedi, Azeez Alzafiri, Maitham Adel, Enas F. Gouda, Husain Awad, Nashmi Alshammari, Alia Embaireeg, Sondas Ibrahim Alsharidah, Fatma Alhuraish, Wasel Al-Adsani, Hussain Arian
Publikováno v:
SSRN Electronic Journal.
Background: The transfusion of COVID-19 convalescent plasma (CCP) is being considered to improve clinical outcomes in patients with COVID-19 disease. We investigated the effectiveness of CCP therapy in patients withmoderate and severe COVID-19 diseas